Association of The Uric Acid-To-High-Density Lipoprotein Cholesterol Ratio with Coronary Artery Disease in Patients Younger Than 45 Years Presenting with Stable Chest Pain

Authors

  • Athar Sajjad Department of Cardiology, Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Azhar Ali Chaudhary Department of Cardiology, Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Usman Iqbal Department of Cardiology, Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Iftikhar Ahmed Department of Cardiology, Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Junaid Arshad Department of Cardiology, Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Sanaullah Khan Department of Cardiology, Armed Forces Institute of Cardiology/National Institute of Heart Diseases/National University of Medical Sciences (NUMS) Rawalpindi Pakistan

DOI:

https://doi.org/10.51253/pafmj.v76iSUPPL-9.14094

Keywords:

Coronary Artery Disease, Uric Acid to HDL Ratio, Younger Patients

Abstract

Objective: To investigate the frequency of coronary artery disease in patients younger than 45 years presenting with stable chest pain and then to compare the uric acid to HDL ratio in patients with and without coronary artery disease.

Study Design: Cross-sectional survey.

Place and Duration of Study: Armed Forces Institute of Cardiology & National Institute of Heart Diseases, Rawalpindi, Pakistan, from Jul to Nov 2025.

Methodology: After meeting the selection criteria, a total of 200 patients were enrolled. Patients underwent coronary angiography. Based on the findings, they were categorized into two groups: with coronary artery disease or without coronary artery disease. The angiographic procedure was performed by a single team of cardiologists with assistance from the researcher, under local anesthesia. Blood samples were collected using a 3 cc disposable syringe to assess the uric acid-to-HDL ratio.

Results: In this study, 143(71.5%) were male, 163(81.5%) were hypertensive, and 75(37.5%) were diabetic. Regarding the outcome variable, CAD was detected in 125(62.5%) patients. The median uric acid to HDL ratio was 0.34 (IQR: 0.16) in patients with CAD, compared to 0.08 (IQR: 0.03) in those without CAD (p<0.001).

Conclusion: It can be concluded that the frequency of coronary artery disease was 62.5% among patients younger than 45 years presenting with stable chest pain, and the uric acid to HDL ratio showed a significant association with coronary artery disease.

Downloads

Download data is not yet available.

References

1. Zhang DP, Baituola G, Wu TT, Chen Y, Hou XG, Yang Y, et al. An elevated monocyte-to-high-density lipoprotein–cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI. Biosci Rep 2020; 40(8): BSR20201108. https://doi.org/10.1042/BSR20201108

2. Shahjehan RD, Bhutta BS. Coronary artery disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Available from:

https://www.ncbi.nlm.nih.gov/books/NBK564304/

3. Aydın C, Emlek N. The relationship between uric acid-to-high-density lipoprotein cholesterol ratio and collateral index in patients with chronic total occlusion. Kardiologia 2021; 61(9): 50-56. https://doi.org/10.18087/cardio.2021.9.n1750

4. Tanunyutthawongse C, Khuancharee K, Wannaiampikul S. Relationship between serum uric acid and lipid profiles in Thai adults. Indian J Public Health Res Dev 2020; 11(3): 1420-1425.

5. Mansiroglu AK, Cekici Y, Sincer I, Gunes Y. Serum uric acid and uric acid to HDL-cholesterol ratio in coronary artery fistulas. Ann Med Res 2019; 26(12): 2771-2775.

https://doi.org/10.5455/annalsmedres.2019.08.479

6. Matsumoto I, Moriya S, Kurozumi M, Namba T, Takagi Y. Relationship between serum uric acid levels and the incidence of cardiovascular events after percutaneous coronary intervention. J Cardiol 2021; 78(6): 550-557.

https://doi.org/10.1016/j.jjcc.2021.08.005

7. Mansiroglu AK, Cosgun M, Sincer I, Gunes Y. A promising marker in patients with coronary artery ectasia: Uric acid/HDL ratio. Ann Med Res 2021; 28(2): 312-315.

https://doi.org/10.5455/annalsmedres.2020.06.584

8. Bailey A, Mohiuddin SS. Biochemistry, high-density lipoprotein. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Available from:

https://www.ncbi.nlm.nih.gov/books/NBK557850/

9. Linton MF, Yancey PG, Tao H, Davies SS. HDL function and atherosclerosis: reactive dicarbonyls as promising targets of therapy. Circ Res 2023; 132(11): 1521-1545.

https://doi.org/10.1161/CIRCRESAHA.123.321563

10. Yaman M, Kilinc AY, Öztürk F, Coşkun M, Duz R, Gunes Y. Relationship between uric acid to HDL ratio and extent and severity of coronary artery disease. Postępy Kardiol Interwencyjnej 2024; 20(1): 401-405.

https://doi.org/10.5114/aic.2024.145034

11. Murugan J, Balasubramaniyan JV, Mathiyalagan PK, Ramesh Y, Selvam M, Charley C, et al. Characteristics and treatment analysis of young acute coronary syndrome patients in a tertiary care hospital: a cross-sectional retrospective study. Health Sci Rep 2023; 6(3): e1141.

https://doi.org/10.1002/hsr2.1141

12. Balouch IJ, Ahmed I, Farooq F, Raza SA, Soomro NA, Khan MN, et al. Pattern of coronary artery diseases in patients under 40 years of age with acute coronary syndrome. Pak Heart J 2021; 54(2): 144-147. https://doi.org/10.47144/phj.v54i2.2089

13. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol 2020; 76(25): 2982-3021.

https://doi.org/10.1016/j.jacc.2020.11.010

14. Enomoto M, Adachi H, Hirai Y, Fukami A, Satoh A, Otsuka M, et al. LDL-C/HDL-C ratio predicts carotid intima-media thickness progression better than HDL-C or LDL-C alone. J Lipids 2011; 2011: 549137. https://doi.org/10.1155/2011/549137

15. Ur Rehman M, Ahmed I, Alam F, Sadiq MW, Mustafa A, Hussain Z, et al. Pattern of coronary artery disease in young patients with acute coronary syndrome. J Health Rehabil Res 2023; 3(2): 1068-1072.

https://doi.org/10.61919/jhrr.v3i2.296

16. Anwar M, Nadeem A, Siddique MB, Toru FK, Khawaja AZ, Malik SP. Uric acid/HDL ratio as a marker of disease in coronary artery ectasia versus normal coronaries. Pak Armed Forces Med J 2024; 74(Suppl-1): S1-S5.

https://doi.org/10.51253/pafmj.v74iSUPPL-1.10594

17. Li F, Zhao D, Li Q, Lin X, Sun H, Fan Q. Uric acid to high-density lipoprotein cholesterol ratio is a novel marker to predict functionally significant coronary artery stenosis. J Interv Cardiol 2022; 2022: 9057832. https://doi.org/10.1155/2022/9057832

18. Kuwabara M, Ae R, Kosami K, Kanbay M, Andres-Hernando A, Hisatome I, et al. Current updates and future perspectives in uric acid research, 2024. Hypertens Res 2025; 48(2): 867-873.

https://doi.org/10.1038/s41440-024-02031-9

19. Chang DY, Wang JW, Chen M, Zhang LX, Zhao MH. Association between serum uric acid level and mortality in China. Chin Med J 2021; 134(17): 2073-2080.

https://doi.org/10.1097/CM9.0000000000001631

20. Li N, Cui L, Shu R, Song H, Wang J, Chen S, et al. Associations of uric acid with the risk of cardiovascular disease and all-cause mortality among individuals with chronic kidney disease: the Kailuan study. Eur J Prev Cardiol 2024; 31(17): 2058-2066.

https://doi.org/10.1093/eurjpc/zwae222

Downloads

Published

30-09-2026

How to Cite

1.
Athar Sajjad, Azhar Ali Chaudhary, Usman Iqbal, Iftikhar Ahmed, Junaid Arshad, Sanaullah Khan. Association of The Uric Acid-To-High-Density Lipoprotein Cholesterol Ratio with Coronary Artery Disease in Patients Younger Than 45 Years Presenting with Stable Chest Pain. Pak Armed Forces Med J [Internet]. 2026 Sep. 30 [cited 2026 Oct. 6];76(SUPPL-9):S1478-S1482. Available from: https://www.pafmj.org/PAFMJ/article/view/14094